SubsidieMeestersInnovating iN Smart Programmable IntegRatEd photonics
The INSPIRE project aims to develop and demonstrate programmable photonic processors (FPPGAs) for enhanced computing performance and efficiency, targeting TRL5/6 readiness with three innovative prototypes.
Projectdetails
iPronics has pioneered Field Programmable Photonic Gate Arrays (FPPGA), an entirely new class of powerful, flexible photonic processors for computing applications in the optical sphere.
Introduction
Unlike electronic FPGAs, they use optical interference to perform very high-speed analog operations. This delivers major increases in system performance and reduced power consumption.
Project Overview
Our project INSPIRE (Innovating iN Smart Programmable IntegRatEd photonics) will make FPPGA programmable photonics available in the form of TRL5/6 demonstrators for the first time.
Technology Advancement
INSPIRE will advance our current technology readiness by:
- Increasing the number of programmable unit cells per chip.
- Improving key performance characteristics including power consumption, space requirements, and chip coupling losses.
This new optical layer design is then produced in a pilot batch ready for functional tests, validation, and demonstration.
Complementary Development
We will concurrently develop the complementary electronics and software needed to drive, monitor, and program this newly developed field-programmable photonic gate arrays (FPPGAs).
Market Engagement
To ensure our target specifications meet market requirements, we will involve early adopters. We will validate the potential of programmable photonics in the form of three prototypes ready for demonstration:
- A general-purpose starter kit suitable for education, R&D, and simple applications.
- An RF-Photonics demonstrator designed to accelerate waveform processing in mobile communication networks.
- A Photonic Computing demonstrator that will speed up data centre operations.
Future Steps
We will advance beyond the current TRL4/BRL3 to at least TRL6/BRL5 by validating and demonstrating the newly developed solution with pilot users from selected verticals. The results will be used to update our business case, refine our business model, and prepare for scale-up and market entry in a follow-on project.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.453.292 |
| Totale projectbegroting | € 2.453.292 |
Tijdlijn
| Startdatum | 1-4-2022 |
| Einddatum | 31-3-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- IPRONICS PROGRAMMABLE PHOTONICS,SLpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Three dimensional INtegrated PhotonIcS to RevolutionizE deep LearningThis project aims to develop advanced photonic neural network processors to significantly enhance computational efficiency and scalability, revolutionizing AI hardware and applications. | ERC COG | € 1.998.918 | 2022 | Details |
LIQuid-crystal enabled Universal Optical Reconfigurable Integrated Circuit EngineeringLIQUORICE aims to develop a programmable photonic processor for rapid prototyping in diverse applications, enhancing innovation and measurement capabilities in photonics technology. | ERC POC | € 150.000 | 2022 | Details |
Integrated photonic circuit fabrication by femtosecond laser writing for quantum informationThe PhotonFAB project aims to enhance the production of integrated photonic devices for quantum applications using femtosecond laser writing, targeting commercial viability and market expansion. | ERC POC | € 150.000 | 2022 | Details |
Large-scale Multicore Smart Photonics: Using advanced design and configuration protocols to develop the largest-scale programmable photonic processorThe project aims to develop a large-scale multicore programmable photonic processor to enhance scalability and performance in integrated photonics for complex neuromorphic computing applications. | ERC STG | € 1.499.325 | 2023 | Details |
Three dimensional INtegrated PhotonIcS to RevolutionizE deep Learning
This project aims to develop advanced photonic neural network processors to significantly enhance computational efficiency and scalability, revolutionizing AI hardware and applications.
LIQuid-crystal enabled Universal Optical Reconfigurable Integrated Circuit Engineering
LIQUORICE aims to develop a programmable photonic processor for rapid prototyping in diverse applications, enhancing innovation and measurement capabilities in photonics technology.
Integrated photonic circuit fabrication by femtosecond laser writing for quantum information
The PhotonFAB project aims to enhance the production of integrated photonic devices for quantum applications using femtosecond laser writing, targeting commercial viability and market expansion.
Large-scale Multicore Smart Photonics: Using advanced design and configuration protocols to develop the largest-scale programmable photonic processor
The project aims to develop a large-scale multicore programmable photonic processor to enhance scalability and performance in integrated photonics for complex neuromorphic computing applications.